Core Technology

Cellid Co.,Ltd. leads development of anti-cancer immunotherapy.

Original CeliVax Technology

  • CeliVax uses patient-derived B cells and monocytes.
  • CeliVax is applicable to all cancers with identified antigens.
  • CeliVax consists of Antigen Presenting Cells (APCs), tumor-associated antigen genes, and an adjuvant.